Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in (Q81126148)
Jump to navigation
Jump to search
scientific article published on 21 April 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in |
scientific article published on 21 April 2008 |
Statements
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing (English)
Victoria L Vetter
Josephine Elia
Christopher Erickson
Stuart Berger
Nathan Blum
Karen Uzark
Catherine L Webb
American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee
American Heart Association Council on Cardiovascular Nursing